Literature DB >> 1712032

Anti-myelin-associated glycoprotein antibodies in patients with a monoclonal IgM gammopathy and polyneuropathy, and a simplified method for the preparation of glycolipid antigens.

D Burger1, G Perruisseau, A J Steck.   

Abstract

The two sulfated glucuronic acid containing glycolipids, sulfate-3-glucuronyl paragloboside (SGPG) and sulfate-3-glucuronyl lactosaminyl paragloboside (SGLPG), were prepared by ion exchange chromatography of lipid extracts from bovine cauda equina. Thin layer chromatography (TLC) immunostaining and an enzyme-linked immunosorbent assay (ELISA) were used to show that the SGPG/SGLPG fraction was free of crossreactive antigenic components such as gangliosides. The results obtained by ELISA demonstrate that sera of all patients were validated IgM monoclonal anti-myelin-associated glycoprotein (MAG) demyelinating neuropathy display high titer antibodies with high affinity type titration curves. These antibodies were absent from the sera of 16 patients with other neurological diseases and ten normal controls. ELISA with SGPG/SGLPG as an antigen appears to be a valuable and highly specific immunodiagnostic test for determining anti-MAG antibody titers in the sera of patients. The amount (approximately 0.4 mg) of SGPG/SGLPG partially purified from 10 g of fresh tissue is sufficient for the preparation of approximately 100 96-well plates for ELISA procedures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712032     DOI: 10.1016/0022-1759(91)90123-w

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

Review 1.  Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases.

Authors:  E Ellie; A Vital; A Steck; J M Boiron; C Vital; J Julien
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

2.  Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy.

Authors:  Ruben Herrendorff; Pascal Hänggi; Hélène Pfister; Fan Yang; Delphine Demeestere; Fabienne Hunziker; Samuel Frey; Nicole Schaeren-Wiemers; Andreas J Steck; Beat Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

3.  Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope.

Authors:  P Fredman; J Lycke; O Andersen; M Vrethem; J Ernerudh; L Svennerholm
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

4.  Immunoglobulin (Ig) M antibody against myelin associated glycoprotein (MAG): A comparison of methods.

Authors:  T D Jaskowski; T B Martins; C M Litwin; H R Hill
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

5.  Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain.

Authors:  F H Azmi; A H Lucas; H L Spiegelberg; D M Granoff
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.